VASH1 and lung carcinoma: miR-143-3p targets 3′-UTR of vasohibin-1 (VASH1) mRNA and represses its expression, thereby promoting the EMT, invasion in an in vitro blood-brain barrier model, and angiogenesis of lung cancer cells [89].